Study on the Treatment of Children With Purpura Nephritis With Huaiqihuang Granules
Status:
Not yet recruiting
Trial end date:
2021-08-30
Target enrollment:
Participant gender:
Summary
About 20% children with allergic purpura develop nephritis syndrome or nephrotic syndrome, 1%
to 7% to kidney failure or end-stage renal disease. Children with serious damage to health,
significantly reduced quality of life and caused heavy economic burden to the family . As the
pathogenesis of HSPN is complex, it is difficult to formulate an exact individualized
treatment plan.
Phase:
Early Phase 1
Details
Lead Sponsor:
The Children's Hospital of Zhejiang University School of Medicine